Abstract
PET has been extremely useful in evaluating the treatment response to chemotherapy or radiotherapy in patients with various neoplastic disorders. Little is known about the clinical usefulness of fluorine-18 fluorodeoxyglucose (FDG) PET for assessing the treatment response, however, and few studies have been described in patients with inflammatory or infectious diseases. Most of the studies demonstrate a definite role of FDG-PET in the diagnosis and evaluation of the treatment response and disease activity in patients with vasculitis. In other inflammatory or infectious diseases, only a few studies with a limited number of patients have been published. Nevertheless, if we extrapolate the use of PET in inflammatory or infectious diseases, it can be assumed that PET may hold a promising future role in the follow-up of inflammatory or infectious diseases.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 191-198 |
| Number of pages | 8 |
| Journal | PET Clinics |
| Volume | 1 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2006 |
| Externally published | Yes |
Bibliographical note
Copyright:Copyright 2009 Elsevier B.V., All rights reserved.